1. Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, et al. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2020; 142(1):e7–22. PMID:
32476490.
2. Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy:
JACC State-of-the-Art Review. J Am Coll Cardiol. 2019; 73(22):2872–2891. PMID:
31171094.
3. Kharoubi M, Bézard M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, et al. History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis. ESC Heart Fail. 2021; 8(6):5501–5512. PMID:
34714605.
4. Griffin JM, Rosenthal JL, Grodin JL, Maurer MS, Grogan M, Cheng RK. ATTR amyloidosis: current and emerging management strategies:
JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2021; 3(4):488–505. PMID:
34729521.